|
|
|
|
What is a digital twin, and what potential does it have in regulated environments such as pharmaceutical manufacturing? Learn how digital twins are revolutionizing GxP manufacturing in the pharmaceutical industry and what they make possible from regulatory, quality, bioprocess, and technological perspectives.
|
|
|
|
|
The Parenteral Drug Association (PDA) is developing an AI Glossary to standardize terminology across drug manufacturing. In the meantime, build your knowledge by familiarizing yourself with essential AI concepts, including explainability, data integrity, validation, governance, digital twins, in-process deployment, and monitorization.
|
|
|
|
|
In the pharmaceutical industry, the need for continuous improvement in production and quality has always been balanced with stringent regulations. Gain insights into why 2025 is set to be a transformative year for AI in the pharmaceutical industry, driven by regulatory clarity, technological advancements, and growing industry adoption.
|
|
|
|
|
AI is transforming pharmaceutical manufacturing, driven by recent initiatives from the FDA and PDA. Learn about these initiatives that provide frameworks and guidance for integrating AI into pharmaceutical manufacturing, making it easier than ever before for the industry to delve into the future of AI in GxP environments.
|
|
|
